TrialThe international journal of neuropsychopharmacology2021

A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder.

Henry R Kranzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.